VALUATION METHOD UNDER §160 DEBATED BEFORE SUPREME COURT Klang v. Smith's Food & Drug Centers | Secondary Sources | Westlaw

VALUATION METHOD UNDER §160 DEBATED BEFORE SUPREME COURT Klang v. Smith's Food & Drug Centers | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, VALUATION METHOD UNDER §160 DEBATED BEFORE SUPREME COURT Klang v. Smith's Food & Drug Centers, Secondary Sources
Skip Page Header

VALUATION METHOD UNDER §160 DEBATED BEFORE SUPREME COURT Klang v. Smith's Food & Drug Centers

1997 ANCODLLR 21690Andrews Corporate Officers and Directors Liability Litigation Reporter (Approx. 3 pages)

VALUATION METHOD UNDER §160 DEBATED BEFORE SUPREME COURT Klang v. Smith's Food & Drug Centers

1997 ANCODLLR 21690Andrews Corporate Officers and Directors Liability Litigation Reporter (Approx. 3 pages)

1997 Andrews Corp. Off. & Directors Liab. Litig. Rep. 21690
Andrews Corporate Officers and Directors Liability Litigation Reporter
October 22, 1997
Valuation
Copyright (c) 1997 Andrews Publications

VALUATION METHOD UNDER §160 DEBATED BEFORE SUPREME COURT

Klang v. Smith's Food & Drug Centers

Even if the board of Smith's Food & Drug Centers (SFD) could revalue the company's assets as part of a stock buyback and merger deal, the company still owed more than it was worth and shareholders were entitled to know that before they voted on the...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.